A 12-week prospective pharmacovigilance study using the PvPI form, WHO-UMC, Naranjo, Hartwig and Schumock–Thornton scales
- PvPI Suspected Adverse Drug Reaction Reporting Form
- WHO-UMC causality assessment system
- Naranjo ADR probability scale
- Modified Hartwig and Siegel severity scale
- +3